3 Result(s)
-
Article
Open AccessEvaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations
Regulatory agencies, such as the European Medicines Agency and Health Canada, are requiring the public sharing of clinical trial reports that are used to make drug approval decisions. Both agencies have provid...
-
Article
Open AccessPhysician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak
Privacy concerns by providers have been a barrier to disclosing patient information for public health purposes. This is the case even for mandated notifiable disease reporting. In the context of a pandemic it ...
-
Article
Methods for the de-identification of electronic health records for genomic research
Electronic health records are increasingly being linked to DNA repositories and used as a source of clinical information for genomic research. Privacy legislation in many jurisdictions, and most research ethic...
